Drugbank Logo

Search Results

Search for "Cefuroxime" returned 6 results

Showing 1-6 out of 6
DrugBank ID Name Formula Weight
DB01112
DrugCard button for DB01112
Cefuroxime C16H16N4O8S 424.3850
Cefuroxime Cefuroxime is a β-lactam type antibiotic. More specifically, it is a second-generation cephalosporin. Cephalosporins work the same way as penicillins: they interfere with the ...
DB00479
DrugCard button for DB00479
Amikacin C22H43N5O13 585.6025
... of nephrotoxicity Ceftriaxone Increased risk of nephrotoxicity Cefuroxime Increased risk of nephrotoxicity Cephapirin Increased risk of nephrotoxicity Cisplatin Increased risk of ...
DB01032
DrugCard button for DB01032
Probenecid C13H19NO4S 285.3590
... level Ceftizoxime Probenecid increases the antibiotic's level Cefuroxime Probenecid increases the antibiotic's level Cephalexin Probenecid increases the antibiotic's level Cephaloglycin ...
DB00798
DrugCard button for DB00798
Gentamicin C21H43N5O7 477.5954
... of nephrotoxicity Ceftriaxone Increased risk of nephrotoxicity Cefuroxime Increased risk of nephrotoxicity Cephalothin Group Increased risk of nephrotoxicity Cephapirin Increased risk of ...
DB00955
DrugCard button for DB00955
Netilmicin C21H41N5O7 475.5795
... of nephrotoxicity Ceftriaxone Increased risk of nephrotoxicity Cefuroxime Increased risk of nephrotoxicity Cephalothin Group Increased risk of nephrotoxicity Cephapirin Increased risk of ...
DB00684
DrugCard button for DB00684
Tobramycin C18H37N5O9 467.5145
... of nephrotoxicity Ceftriaxone Increased risk of nephrotoxicity Cefuroxime Increased risk of nephrotoxicity Cephalothin Group Increased risk of nephrotoxicity Cephapirin Increased risk of ...
Showing 1-6 out of 6

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.